SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form C - Offering Statement:
SEC Accession No. 0001669191-21-000435
Filing Date
2021-04-26
Accepted
2021-04-26 16:32:16
Documents
8

Document Format Files

Seq Description Document Type Size
1 primary_doc.html C  
1 primary_doc.xml C 9905
2 OFFERING STATEMENT PDF offeringstatement.pdf EX-99 119040
3 OFFERING PAGE JPG offeringpage.jpg GRAPHIC 2046555
4 CPA REVIEW REPORT reviewletter.pdf EX-99 178293
5 CERTIFICATE OF INCORPORATION certificateofincorporation.pdf EX-99 4013072
6 CORPORATE BYLAWS corporatebylaws.pdf EX-99 10026208
7 ADDITIONAL INFORMATION otherfinancial.pdf EX-99 140687
8 IMAGE ATTACHMENTS HTML imageattachments.htm EX-99 244
  Complete submission text file 0001669191-21-000435.txt   22771099
Mailing Address 237 KEARNY STREET #9171 SAN FRANCISCO CA 94108
Business Address 237 KEARNY STREET #9171 SAN FRANCISCO CA 94108 8664151001
Bioverge, Inc. (Filer) CIK: 0001828649 (see all company filings)

IRS No.: 822592905 | State of Incorp.: CA | Fiscal Year End: 1231
Type: C | Act: 33 | File No.: 020-27997 | Film No.: 21854267